Midwifery

 Ferring’s Propess® is the first pharmacological treatment for cervical ripening to be approved in Japan for over 20 years

Retrieved on: 
Thursday, January 23, 2020
Research, Medical devices, Women, Baby, Maternity, Biotechnology, Health, Consumer, Pharmaceutical, Science, Childbirth, Human reproduction, Medicine, Midwifery, Obstetrics, Health, Labor induction, Theriogenology, RIPE, Cervical effacement, Cervix, Cervical, Propess5, labour6

This approval offers women requiring an induction in Japan greater choice of alternatives to mechanical methods of cervical ripening.

Key Points: 
  • This approval offers women requiring an induction in Japan greater choice of alternatives to mechanical methods of cervical ripening.
  • The approval of Propess in Japan is a big step forward in offering women more choice when it comes to cervical ripening, said Per Falk, President and Chief Science Officer, Ferring Pharmaceuticals.
  • Propess is currently marketed in over 60 countries and was developed in the 1980s in Scotland where it continues to be manufactured.
  • If during examination of the cervix length, positioning and softening, it is deemed unfavourable, then cervical ripening will be initiated.

Boston Premiere of Brazilian Documentary, Women of Earth, Shows Power of Indigenous Midwives

Retrieved on: 
Thursday, January 23, 2020
Film & Motion Pictures, Baby, Maternity, Health, General Health, Women, General Entertainment, Events, Concerts, Entertainment, Celebrity, Family, Consumer, Midwifery, Midwife, Midwives, Creative works

The film follows a young Brazilian woman with a dream of becoming a midwife who journeys through indigenous villages and rural communities in search of traditional midwives and the wisdom that they share ( www.womenofearthfilm.com ).

Key Points: 
  • The film follows a young Brazilian woman with a dream of becoming a midwife who journeys through indigenous villages and rural communities in search of traditional midwives and the wisdom that they share ( www.womenofearthfilm.com ).
  • The film is directed by three Brazilian women: Mayara Boaretto (who has since been trained as a midwife), Isadora Carneiro, and Oscar-nominated director Ktia Lund.
  • When I heard the news that the premiere would be in Boston, I found it significant.
  • She writes, Women of Earth beautifully reveals the priceless wisdom that has been preserved by midwives in Brazil for years.

“Seeing Red”: New Book Addresses Period Shame and Advocates for Total Women’s Health

Retrieved on: 
Wednesday, January 22, 2020
Entertainment, Health, Consumer, Women, Books, General Health, Articles, Midwifery, Contents, Women's health, Menstruation, RTT, Menstrual cycle, Health

Karchmer breaks down the history of menstruation, the importance of a healthy cycle and why it is one of the most powerful indicators of womens health.

Key Points: 
  • Karchmer breaks down the history of menstruation, the importance of a healthy cycle and why it is one of the most powerful indicators of womens health.
  • There is enormous power in what our periods are communicating throughout our cyclethey are the single most instructive feedback mechanism for womens health and fertility.
  • I wrote this book to change the conversation around womens health and liberate women of the perceived burden of their period.
  • Kirsten Karchmer is a health tech pioneer and integrative womens health expert.

Clinical Innovations celebrates 20 years of helping mothers, babies with Kiwi® Vacuum-Assisted Delivery System

Retrieved on: 
Tuesday, January 21, 2020
Other Health, General Health, Family, Consumer, Medical devices, Hospitals, Parenting, Other Consumer, Baby, Maternity, Women, Biotechnology, Health, Birds, Articles, Midwifery, RTT, Medical equipment, Childbirth, Kiwi, Vacuum, Dinosaurs, Clinical Innovations, EQT, LABORIE Medical Technologies

Clinical Innovations is celebrating 20 years of the Kiwi Vacuum-Assisted Delivery System by strengthening the pioneering clinician training program that has seen more than 11 million of the hand-pump devices deployed worldwide.

Key Points: 
  • Clinical Innovations is celebrating 20 years of the Kiwi Vacuum-Assisted Delivery System by strengthening the pioneering clinician training program that has seen more than 11 million of the hand-pump devices deployed worldwide.
  • The Kiwi is a single-use, complete vacuum delivery system used to assist physicians when needed to safely deliver babies in any fetal head position.
  • A thorough, widespread training program has been integral to the Kiwis success since Clinical Innovations introduced it two decades ago.
  • The Kiwi vacuum is an accessible solution that truly embodies our mission, said Ken Reali, Clinical Innovations president and CEO.

Sera Prognostics to Present at the 38th Annual JP Morgan Healthcare Conference

Retrieved on: 
Monday, January 13, 2020
Health, Consumer, Women, Other Health, Baby, Maternity, General Health, Women's health, RTT, Midwifery, Human reproduction, Health, Human development, Obstetrics, Infancy, Preterm birth, Pregnancy, Prenatal care, Complications of pregnancy

Seras management will be available for one-on-one meetings with conference attendees after the presentation.

Key Points: 
  • Seras management will be available for one-on-one meetings with conference attendees after the presentation.
  • Sera Prognostics is the leading health diagnostics company dedicated to improve the lives of women and babies through individualized prenatal care.
  • Sera delivers pivotal information to physicians to improve health and to improve the economics of healthcare delivery for pregnant women.
  • Sera is developing innovative diagnostic tests focused on the early prediction of preterm birth risk and other complications of pregnancy.

Alydia Health Announces the Addition of Erica Rogers to its Board of Directors

Retrieved on: 
Friday, January 10, 2020
General Health, Medical devices, Hospitals, Health, Clinical trials, Midwifery, Articles, Motherhood, Women's health, RTT, Human reproduction, Childbirth, Postpartum period, Maternal health, Postpartum bleeding, Health, Postpartum Hemorrhage and Abnormal Postpartum Uterine Bleeding, Alydia Health

Ms. Rogers has successfully driven nearly every aspect of a companys growth, from founding to commercializing some of todays most innovative products on the market.

Key Points: 
  • Ms. Rogers has successfully driven nearly every aspect of a companys growth, from founding to commercializing some of todays most innovative products on the market.
  • Her broad expertise will help Alydia meet our goal of truly changing the standard of care for maternal health in the U.S. and around the world.
  • Alydia Health is addressing this major problem in womens health by focusing on postpartum hemorrhage treatment, said Erica Rodgers.
  • For more information, visit www.alydiahealth.com or follow @AlydiaHealth on Twitter, @Alydia Health on LinkedIn.

Eveline is Helping Couples Conceive in the New Decade with the Help of AI Technology

Retrieved on: 
Tuesday, January 7, 2020
Midwifery, Women\'s health, Articles, Health, Human reproduction, Menstrual cycle, Ovulation, Theriogenology, Fertility

NEW YORK, Jan. 7, 2020 /PRNewswire/ -- Eveline, the world's first AI-powered ovulation prediction kit, aims to help families conceive stress free in the new decade.

Key Points: 
  • NEW YORK, Jan. 7, 2020 /PRNewswire/ -- Eveline, the world's first AI-powered ovulation prediction kit, aims to help families conceive stress free in the new decade.
  • Eveline was created to help make this process simpler and smarter for couples.
  • Eveline uses PixoTech, a mHealth technology, to detect fertility hormone surges and predict women's menstrual cycles.
  • For more information on Eveline, along with further product information on their AI-powered ovulation prediction kit, please visit https://www.evelinecare.com/ .

Maternal Monitoring Solution from AlertWatch Focuses on Maternal Safety During Labor & Delivery

Retrieved on: 
Tuesday, January 7, 2020
Surgery, Technology, Software, Practice Management, Health, Hospitals, Medical devices, Other Health, Baby, Maternity, Consumer, Medical Supplies, Nursing, General Health, Medical specialties, Health, Midwifery, Medicine, RTT, Childbirth, Monitoring, Food and Drug Administration

AlertWatch, Inc ., a leading provider of innovative clinical decision support software, announced the commercial launch of its maternal monitoring system, AlertWatch:OB .

Key Points: 
  • AlertWatch, Inc ., a leading provider of innovative clinical decision support software, announced the commercial launch of its maternal monitoring system, AlertWatch:OB .
  • This rate is three times any other industrialized country, explained AlertWatch founder and University of Michigan anesthesiologist Dr. Kevin Tremper.
  • This novel labor and delivery monitoring system is the first solution to integrate several critical features:
    2) Automated risk assessment for each patient using the ACOG hemorrhage risk guidelines.
  • AlertWatch is the only FDA 510(k)-cleared solution focused entirely on monitoring mothers during, before, and after childbirth, said AlertWatch CEO Justin Adams.

Premier Inc. Analysis: Complications & Common Chronic Conditions Increase Hospitals’ Childbirth Costs by 20 Percent or More

Retrieved on: 
Monday, January 6, 2020
General Health, Women, Hospitals, Consumer, Health, RTT, Childbirth, Medicine, Women's health, Human reproduction, Midwifery, Sexual reproduction, Obstetric surgery, Caesarean section, Vaginal delivery, Vagina, Maternal death

U.S. hospitals could save upwards of 20 percent in costs for complicated childbirths, according to a nationally representative analysis by Premier Inc. (NASDAQ: PINC).

Key Points: 
  • U.S. hospitals could save upwards of 20 percent in costs for complicated childbirths, according to a nationally representative analysis by Premier Inc. (NASDAQ: PINC).
  • The increased costs associated with childbirth are in part due to potentially preventable complications and pre-existing chronic conditions.
  • In aggregate, complications, including severe maternal morbidity (SMM) factors and chronic conditions, add on average 20 percent to the cost to hospitals to perform a vaginal delivery and 25 percent to the cost to perform a cesarean delivery.
  • The cost to provide childbirth care for women who experienced complications or had pre-existing chronic conditions was compared to hospitals' average base cost for an uncomplicated vaginal delivery (about $5,700) and cesarean delivery (about $8,500), per Premiers analysis.

Global Fertility Test Market Set to Reach Over US$271 Million by the year 2025

Retrieved on: 
Tuesday, December 31, 2019
Midwifery, Fertility, Menstrual cycle, Articles, Fertility medicine

DUBLIN, Dec. 31, 2019 /PRNewswire/ -- The "Fertility Test - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 31, 2019 /PRNewswire/ -- The "Fertility Test - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
  • The Fertility Test market worldwide is projected to grow by US$237.1 Million, driven by a compounded growth of 6.9%.
  • Poised to reach over US$271 Million by the year 2025, Ovulation Predictor Kits will bring in healthy gains adding significant momentum to global growth.
  • In Japan, Ovulation Predictor Kits will reach a market size of US$12.6 Million by the close of the analysis period.